CITIGROUP INC - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 178 filers reported holding BLUEBIRD BIO INC in Q1 2022. The put-call ratio across all filers is 1.32 and the average weighting 0.0%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q3 2023$1,696,225
-17.8%
557,969
-11.0%
0.00%0.0%
Q2 2023$2,063,610
-54.3%
627,237
-55.8%
0.00%
-66.7%
Q1 2023$4,512,318
+11.9%
1,418,968
+143.4%
0.00%0.0%
Q4 2022$4,033,467
-33.5%
582,871
-39.2%
0.00%
-25.0%
Q3 2022$6,066,000
+12032.0%
958,408
+7810.3%
0.00%
Q2 2022$50,000
-94.6%
12,116
-93.6%
0.00%
-100.0%
Q1 2022$919,000
-81.9%
189,497
-62.7%
0.00%
-66.7%
Q4 2021$5,070,000
+78.1%
507,458
+240.7%
0.00%
+50.0%
Q3 2021$2,847,000
-48.5%
148,964
-13.9%
0.00%
-33.3%
Q2 2021$5,533,000
+8.2%
173,015
+2.0%
0.00%0.0%
Q1 2021$5,113,000
-37.7%
169,570
-10.6%
0.00%
-40.0%
Q4 2020$8,205,000
-23.8%
189,626
-4.9%
0.01%
-28.6%
Q3 2020$10,763,000
-5.7%
199,500
+6.7%
0.01%
-22.2%
Q2 2020$11,415,000
+39.3%
187,018
+4.9%
0.01%
+12.5%
Q1 2020$8,197,000
-40.2%
178,357
+14.3%
0.01%
-20.0%
Q4 2019$13,696,000
-12.2%
156,082
-8.1%
0.01%
-16.7%
Q3 2019$15,599,000
-39.8%
169,898
-16.6%
0.01%
-42.9%
Q2 2019$25,907,000
+39.5%
203,682
+72.6%
0.02%
+16.7%
Q1 2019$18,565,000
+21.1%
118,002
-23.6%
0.02%
+12.5%
Q4 2018$15,324,000
-46.7%
154,482
-21.5%
0.02%
-38.5%
Q3 2018$28,724,000
-55.7%
196,746
-52.3%
0.03%
-55.9%
Q2 2018$64,786,000
+184.3%
412,785
+209.3%
0.06%
+227.8%
Q1 2018$22,786,000
-42.8%
133,453
-40.4%
0.02%
-43.8%
Q4 2017$39,852,000
+111.2%
223,760
+62.9%
0.03%
+100.0%
Q3 2017$18,866,000
+32.6%
137,352
+1.4%
0.02%
+23.1%
Q2 2017$14,230,000
+60.5%
135,470
+38.9%
0.01%
+62.5%
Q1 2017$8,865,000
-9.7%
97,528
-38.7%
0.01%
-11.1%
Q4 2016$9,820,000
-18.1%
159,140
-10.1%
0.01%
-10.0%
Q3 2016$11,997,000
+57.9%
176,988
+0.9%
0.01%
+25.0%
Q2 2016$7,596,000
+33.6%
175,466
+31.2%
0.01%
+33.3%
Q1 2016$5,685,000
-41.5%
133,771
-11.6%
0.01%
-40.0%
Q4 2015$9,720,000
+5.1%
151,350
+40.0%
0.01%
+11.1%
Q3 2015$9,249,000
-21.0%
108,102
+55.6%
0.01%
-10.0%
Q2 2015$11,702,000
+1042.8%
69,496
+718.5%
0.01%
+900.0%
Q1 2015$1,024,000
+1.1%
8,491
-23.0%
0.00%0.0%
Q4 2014$1,013,000
+3651.9%
11,034
+1357.6%
0.00%
Q3 2014$27,000
-40.0%
757
-34.8%
0.00%
Q2 2014$45,000
-55.9%
1,161
-74.0%
0.00%
Q1 2014$102,000
-1.9%
4,457
-10.6%
0.00%
Q4 2013$104,000
+1200.0%
4,986
+1567.6%
0.00%
Q3 2013$8,0002990.00%
Other shareholders
BLUEBIRD BIO INC shareholders Q1 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 5,910,687$24,470,0003.71%
Monaco Asset Management SAM 306,142$1,267,0000.55%
Parametrica Management Ltd 90,105$374,0000.41%
Kamunting Street Capital Management, L.P. 55,200$229,0000.31%
Birchview Capital, LP 98,000$406,0000.30%
Kamunting Street Capital Management, L.P. 35,000$145,0000.20%
PDT Partners, LLC 519,477$2,151,0000.19%
Graham Capital Management, L.P. 781,912$3,237,0000.13%
CAXTON ASSOCIATES LP 220,154$911,0000.09%
Baker Brothers Advisors 2,499,715$10,349,0000.06%
View complete list of BLUEBIRD BIO INC shareholders